Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells

Nigel P. Mongan; Lorraine J. Gudas

doi:10.1158/1535-7163.MCT-04-0079

AACR Journals

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
Search More

Search for this keyword

Advanced Search

AACR Journals

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
Search More

Search for this keyword

Advanced Search

Article

Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells

Nigel P. Mongan and Lorraine J. Gudas

Nigel P. Mongan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lorraine J. Gudas

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1535-7163.MCT-04-0079 Published March 2005

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2005 to August 2020

	Abstract	Full-text HTML	PDF
Total	2965	5196	2813

Cited By

Article Information

Volume 4, Issue 3, pp. 477-486

DOI

https://doi.org/10.1158/1535-7163.MCT-04-0079

PubMed

15767557

Published By

American Association for Cancer Research

Print ISSN

1535-7163

Online ISSN

1538-8514

History

January 5, 2005
March 22, 2004
December 22, 2004
Published first March 14, 2005.

American Association for Cancer Research

Author Information

Nigel P. Mongan and
Lorraine J. Gudas

Department of Pharmacology, Weill Medical College, Cornell University, New York, New York

Requests for reprints: Lorraine J. Gudas, Department of Pharmacology, Weill Medical College, Cornell University, 1300 York Avenue, New York, NY 10021. Phone: 212-746-6250; Fax: 212-746-8858. E-mail: ljgudas{at}med.cornell.edu

View Full Text

PreviousNext

March 2005
Volume 4, Issue 3

Table of Contents
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells

Message Subject (Your Name) has forwarded a page to you from Molecular Cancer Therapeutics

Message Body (Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells

Nigel P. Mongan and Lorraine J. Gudas

Mol Cancer Ther March 1 2005 (4) (3) 477-486; DOI: 10.1158/1535-7163.MCT-04-0079

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells

Nigel P. Mongan and Lorraine J. Gudas

Mol Cancer Ther March 1 2005 (4) (3) 477-486; DOI: 10.1158/1535-7163.MCT-04-0079

Share This Article: